The projects under the TB & HIV theme have a long standing partnership with different organisations and academic institutions. The main partners include;
The University of Malawi’s College of Medicine (COM)
The University of Malawi’s College of Medicine (COM) is the country’s largest medical school with an intake of 115 students per year and a faculty of 134. COM has a research strategy that focuses on developing the scientific talent and building the capacity and infra-structure to undertake research programmes addressing the major diseases of Malawi. Six priority areas have been identified by COM: Maternal and adolescent health, Bioethics, Health systems, Nutrition and Early Child Development, HIV Clinical Trials and Implementation Science and Malaria Prevention and Treatment and there is an emphasis on translational research which can improve health outcomes in Malawi in the near future.
London School of Hygiene and Tropical Medicine
LSHTM The London School of Hygiene & Tropical Medicine is recognised as one of world’s leading universities for collaborative research, and has projects and partnerships in more than 100 countries. The School is engaged in collaborative research with numerous partners across the region, focussing on everything from AIDS and tuberculosis, to cardiovascular diseases and complications of childbirth. MLW is one of the major LSHTM partners. LSHTM is a funder of different projects under the TB & HIV, Malaria etc themes within MLW but also a sponsor for MSc and PhD students.
Liverpool School of Tropical Medicine
LSTM and UoL are both internationally recognised as leaders in tropical and global health research. LSTM’s research activity is almost exclusively focused on the tropics and MLW represents its major overseas clinical research base. LSTM’s strategy is based on translational research to improve the health of populations in resource 3rd world countries. There is a particular focus on areas of strength in Neglected Tropical Diseases, Malaria and Vector borne diseases, Maternal and newborn health, Lung health and tuberculosis, and Antimicrobial resistance research. Substantial expertise in clinical trials, systematic reviews and health delivery research underpin many of these initiatives.
University of Liverpool
The UoL strategic plan 2026 highlights the need to continue to grow international collaborative work as a central element of the university’s mission. Infection is one of the three research themes in which Liverpool will provide global leadership. To deliver this strategy, the Institute for Infection and Global Health (IGH) was established in 2010, bringing together leading medical, veterinary and basic scientists from across the University. The Institute houses the Centre for Global Vaccine Research which connects to MLW as its major overseas partner. IGH acts links substantial expertise in infection pharmacology, AMR, HIV and TB, paediatrics, molecular biology, public health and epidemiology within other UoL institutes to research programmes in Malawi.